Kenneth Rainin Foundation Awards $2.6M to Leading Researchers in IBD

Kenneth Rainin Foundation Awards $2.6M to Leading Researchers in IBD
The Kenneth Rainin Foundation has granted $2.6 million through its Innovator Awards program to researchers working to improve  the diagnosis, treatment and prevention of inflammatory bowel disease (IBD). This funding will go toward supporting cutting-edge research worldwide that may lead to major breakthroughs. The Kenneth Rainin Foundation has doubled the award money, reaching up to $200,000 per research project this year, in an effort to aid researchers working to advance from the discovery phase to a stage that might directly impact patient care. “We are providing more resources to enable researchers to build their body of work. This is especially important for new research projects,” Dr. Laura Wilson, director of health strategy and ventures at the Kenneth Rainin Foundation, said in a press release. “We fund unconventional ideas that could have a greater impact on the lives of those who suffer from IBD.” Grant money awarded will help further the understanding of IBD by supporting various areas of research, such as diet and nutrition, immunity, inflammation, and the microbiome. “This funding will allow us to investigate how genetic predispositions may contribute to the development of IBD, potentially enabling the development of new therapies that might treat or prevent the disease,” said Marcia Goldberg, a professor of medicine at the Massachusetts General Hospital and one of the grant awardees. Grants are awarded to early-stage as well late-stage researchers who are pursuing a range of projects. For 2018, the Innovator Award recipients include Christian Brendel, PhD, at the Dana Farber Cancer Institute and Boston Children’s Hospital; Ajay Chawla, MD, at the University of California, San Francisco; Gerard Eberl, PhD, at the Institu
Subscribe or to access all post and page content.